Use of human small leucine-zipper protein in osteogenesis

摘要

The present invention relates to the use of human small leucine zipper proteins in the bone formation process, and more particularly, to a method of using sLZIP to increase the transcriptional activity of Runx2 and inhibit the transcriptional activity of PPARγ2, thereby increasing osteoblast differentiation. Plays an important role and can be used as a marker for bone disease treatment and drug development.